PTC Therapeutics Stock Forecast
Recent PTC Therapeutics Stock Price |
|
PTC Therapeutics Stock Forecast Price |
$25.49 |
+15.42% |
$29.42 |
As of 2024-04-26
Recent PTC Therapeutics Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
5 |
5 |
5 |
5 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
4 |
4 |
4 |
5 |
Sell ratings: |
2 |
2 |
2 |
2 |
Strong sell ratings: |
3 |
3 |
3 |
3 |
Average rating: |
2.84 |
2.84 |
2.84 |
2.85 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented PTC Therapeutics stock forecast (traded under symbol PTCT), for forward-twelve-months price target as shown at the top of this page, gives you the average PTC Therapeutics stock forecast for forward target price for symbol PTCT, across the 12 analysts covering PTC Therapeutics (PTCT), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median PTC Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher PTC Therapeutics stock forecast and half had a lower PTC Therapeutics stock forecast) was $28.0 as of 2024-04-26 (which is a different mathematical metric versus taking the average or mean), while the
highest PTC Therapeutics stock forecast in the analyst group was $45.0, and the lowest PTC Therapeutics stock forecast in the analyst group was
$15.0, with a standard deviation of $9.336. Get the latest Zacks research report on PTCT — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
Company Name: |
PTC Therapeutics Inc |
Website: |
www.ptcbio.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding PTCT: |
36 |
Total Market Value Held by ETFs: |
$350.39M |
Total Market Capitalization: |
$1.93B |
% of Market Cap. Held by ETFs: |
18.15% |
|
|
April 28, 2024 10:54 AM Eastern
Hold (2.16 out of 4)
0th percentile
|
|